126 related articles for article (PubMed ID: 32862161)
1. Adverse drug reactions of anti-tuberculosis treatment among children with tuberculosis.
Laghari M; Talpur BA; Syed Sulaiman SA; Khan AH; Bhatti Z
Int J Mycobacteriol; 2020; 9(3):281-288. PubMed ID: 32862161
[TBL] [Abstract][Full Text] [Related]
2. Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study.
Lv X; Tang S; Xia Y; Wang X; Yuan Y; Hu D; Liu F; Wu S; Zhang Y; Yang Z; Tu D; Chen Y; Deng P; Ma Y; Chen R; Zhan S
PLoS One; 2013; 8(6):e65037. PubMed ID: 23750225
[TBL] [Abstract][Full Text] [Related]
3. Occurrence, Management, and Risk Factors for Adverse Drug Reactions in Multidrug Resistant Tuberculosis Patients.
Ahmad N; Javaid A; Syed Sulaiman SA; Afridi AK; Zainab ; Khan AH
Am J Ther; 2018; 25(5):e533-e540. PubMed ID: 26938643
[TBL] [Abstract][Full Text] [Related]
4. Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study.
Yang M; Pan H; Lu L; He X; Chen H; Tao B; Liu W; Yi H; Tang S
BMJ Open; 2019 Mar; 9(3):e027321. PubMed ID: 30928962
[TBL] [Abstract][Full Text] [Related]
5. Adverse drug reactions in South African patients receiving bedaquiline-containing tuberculosis treatment: an evaluation of spontaneously reported cases.
Jones J; Mudaly V; Voget J; Naledi T; Maartens G; Cohen K
BMC Infect Dis; 2019 Jun; 19(1):544. PubMed ID: 31221100
[TBL] [Abstract][Full Text] [Related]
6. Adverse drug reactions in children and adolescents on daily antitubercular regimen: An observational longitudinal study.
Agarwal A; H B S; Mathur SB; Kalra BS; Arora R; Khanna A; Rajeshwari K
Indian J Tuberc; 2023; 70 Suppl 1():S76-S81. PubMed ID: 38110265
[TBL] [Abstract][Full Text] [Related]
7. Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors.
Javadi MR; Shalviri G; Gholami K; Salamzadeh J; Maghooli G; Mirsaeedi SM
Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1104-10. PubMed ID: 17823987
[TBL] [Abstract][Full Text] [Related]
8. Design of the anti-tuberculosis drugs induced adverse reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS).
Xia YY; Hu DY; Liu FY; Wang XM; Yuan YL; Tu DH; Chen YX; Zhou L; Zhu LZ; Gao WW; Wang HY; Chen da F; Yang L; He PP; Li XT; He YJ; Sun F; Zhan SY
BMC Public Health; 2010 May; 10():267. PubMed ID: 20492672
[TBL] [Abstract][Full Text] [Related]
9. Incidence and outcomes of adverse drug reactions to first-line anti-tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study.
Choi H; Park HA; Hyun IG; Kim JH; Hwang YI; Jang SH; Sim YS; Shin TR; Ko Y; Ban GY; Hong JY; Lee CY; Lee MG; Choi JH
Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1153-1163. PubMed ID: 35909258
[TBL] [Abstract][Full Text] [Related]
10. Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports.
Njuguna C; Stewart A; Mouton JP; Blockman M; Maartens G; Swart A; Chisholm B; Jones J; Dheda M; Igumbor EU; Cohen K
Drug Saf; 2016 Feb; 39(2):159-69. PubMed ID: 26547719
[TBL] [Abstract][Full Text] [Related]
11. Adverse Drug Reactions Causing Admission to Medical Wards: A Cross-Sectional Survey at 4 Hospitals in South Africa.
Mouton JP; Njuguna C; Kramer N; Stewart A; Mehta U; Blockman M; Fortuin-De Smidt M; De Waal R; Parrish AG; Wilson DPK; Igumbor EU; Aynalem G; Dheda M; Maartens G; Cohen K
Medicine (Baltimore); 2016 May; 95(19):e3437. PubMed ID: 27175644
[TBL] [Abstract][Full Text] [Related]
12. A prospective, observational study of adverse reactions to drug regimen for multi-drug resistant pulmonary tuberculosis in central India.
Hire R; Kale AS; Dakhale GN; Gaikwad N
Mediterr J Hematol Infect Dis; 2014; 6(1):e2014061. PubMed ID: 25237474
[TBL] [Abstract][Full Text] [Related]
13. Correlation between lncRNA AC079767.4 variants and liver injury from antituberculosis treatment in West China.
Zhao Z; Peng W; Wu L; Ying B
J Infect Chemother; 2020 Jan; 26(1):63-68. PubMed ID: 31405785
[TBL] [Abstract][Full Text] [Related]
14. Anti-tuberculosis drugs adverse reactions: a review of the Iranian literature.
Kargar M; Mansouri A; Hadjibabaie M; Javadi M; Radfar M; Gholami K
Expert Opin Drug Saf; 2014 Jul; 13(7):875-91. PubMed ID: 24935479
[TBL] [Abstract][Full Text] [Related]
15. Impact of the change in the antitubercular regimen from three to four drugs on cure and frequency of adverse reactions in tuberculosis patients from Brazil: A retrospective cohort study.
Arriaga MB; Torres NMC; Araujo NCN; Caldas SCC; Andrade BB; Netto EM
PLoS One; 2019; 14(12):e0227101. PubMed ID: 31877199
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Risk Factors Associated with Adverse Drug Reactions among Previously Treated Tuberculosis Patients in China.
Han XQ; Pang Y; Ma Y; Liu YH; Guo R; Shu W; Huang XR; Ge QP; DU J; Gao WW
Biomed Environ Sci; 2017 Feb; 30(2):139-142. PubMed ID: 28292352
[TBL] [Abstract][Full Text] [Related]
17. Assessing the prevalence and effect of adverse drug reactions among patients receiving first line anti-tubercular medicines in the Tamale Teaching Hospital, Ghana.
Amalba A; Bugri AA
Pan Afr Med J; 2021; 38():191. PubMed ID: 33995797
[TBL] [Abstract][Full Text] [Related]
18. 'Have we missed reporting adverse drug reactions under Revised National TB Control Programme?' - A mixed method study in Bengaluru, India.
Krishnappa L; Gadicherla S; Chidambaram P; Anuradha HV; Somanna SN; Naik PR; Das A; Narasimhaiah S; Nagaraja SB
Indian J Tuberc; 2020 Jan; 67(1):20-28. PubMed ID: 32192612
[TBL] [Abstract][Full Text] [Related]
19. Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study.
Massud A; Syed Sulaiman SA; Ahmad N; Shafqat M; Chiau Ming L; Khan AH
Front Pharmacol; 2022; 13():883483. PubMed ID: 35747749
[TBL] [Abstract][Full Text] [Related]
20. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
